Search Results - "Ntoumou, E"

Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes by Ntoumou, E, Tzetis, M, Braoudaki, M, Lambrou, G, Poulou, M, Malizos, K, Stefanou, N, Anastasopoulou, L, Tsezou, A

“…MicroRNAs (miRNAs) in circulation have emerged as promising biomarkers. In this study, we aimed to identify a circulating miRNA signature for osteoarthritis…”
Get full text

Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS) by Bothos, E, Ntoumou, E, Kelaidoni, K, Roukas, D, Drakoulis, N, Papasavva, M, Karakostis, F A, Moulos, P, Karakostis, K

“…Pharmacogenomics describes the link between gene variations (polymorphisms) and drug responses. In view of the implementation of precision medicine in…”
Get full text

A pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment response in patients with psoriasis in the Greek population by Vasilopoulos, Y, Sarri, C, Zafiriou, E, Patsatsi, A, Stamatis, C, Ntoumou, E, Fassos, I, Tsalta, A, Karra, A, Roussaki-Schulze, A, Sotiriadis, D, Mamuris, Z, Sarafidou, T

“…Psoriasis affects 2–3% of the population, causing significant morbidity and financial burden. Immunosuppressive drugs such as cyclosporine are first line…”
Get full text

P.0221 A rapid, concise and robust companion diagnostic pgx test supporting drug selection for diseases of the central nervous system by Roukas, D., Bothos, E., Ntoumou, E., Kelaidoni, K., Drakoulis, N., Papasavva, M., Karakostis, F.A., Moulos, P., Karakostis, K.

Get full text